# Crescent Biopharma, Inc. (CBIO)

> Healthcare · US · Reports in USD

Fundamental indicators from Sponda, adjusted for inflation.

[HTML version](https://sponda.capital/en/CBIO/fundamentals)

## Annual figures

| Year | Revenue (M) | Net Inc. (M) | FCF (M) | Debt (M) | Equity (M) |
| --- | --- | --- | --- | --- | --- |
| 2026 | $ 1.04M | $ -45.97M | $ -36.56M | $ 1.44M | $ 163.26M |
| 2025 | $ 11.10M | $ -157.62M | $ -147.91M | $ 1.64M | $ 203.01M |
| 2024 | $ 0 | $ -51.00M | $ -32.70M | $ 66.8K | $ 5.31M |
| 2023 | $ 10.8K | $ -39.90M | $ -37.74M | $ 808.4K | $ 38.41M |
| 2022 | $ 83.8K | $ -52.16M | $ -51.99M | $ 918.6K | $ 42.93M |
| 2021 | $ 1.38M | $ -75.39M | $ -68.35M | $ 1.92M | $ 81.60M |
| 2020 | $ 12.95M | $ -65.00M | $ -50.08M | $ 2.82M | $ 128.22M |
| 2019 | $ 0 | $ -74.72M | $ -67.29M | $ 3.62M | $ 154.20M |
| 2018 | $ 0 | $ -63.75M | $ -57.39M | $ 0 | $ 205.46M |
| 2017 | $ 0 | $ -44.83M | $ -40.50M | $ 0 | $ 119.70M |
| 2016 | $ 25.5K | $ -43.76M | $ -41.87M | $ 0 | $ 35.30M |
| 2015 | $ 28.18M | $ -17.93M | $ -11.95M | $ 0 | $ 40.47M |
| 2014 | $ 21.23M | $ -15.71M | $ -6.35M | $ 0 | $ 50.80M |
| 2013 | $ 5.68M | $ -15.08M | $ -22.22M | $ 0 | $ 2.91M |
| 2012 | $ 11.14M | $ 2.11M | $ -7.85M | $ 0 | $ 12.53M |

Columns not available in this view: annualPriceMultiples, dividends. They require live market data and are shown on the HTML page instead.

## Leverage and liquidity

| Indicator | Value |
| --- | --- |
| Gross Debt / Eq | 0.01 |
| Liabilities / Eq | 0.12 |
| Current Ratio | 9.66 |

## Other views

- [Metrics](https://sponda.capital/en/CBIO.md)
- [Charts](https://sponda.capital/en/CBIO/charts.md)
- [Compare](https://sponda.capital/en/CBIO/compare.md)
- [Indicator definitions](https://sponda.capital/en/screener.md)

Data as of 2026-08-27.